Apollomics APLM
NASDAQ APLM
$18.60 +0.35 (+1.92%)
As of: Nov 10, 2026 · 1:27 PM EST

Apollomics (APLM) Retained Earnings (2021 - 2025)

Updated

Apollomics (APLM) recorded Retained Earnings of -$711.8 million in Q4 2025, compared with -$700.82 million a year earlier.

Analysis

Apollomics (APLM) Retained Earnings (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Apollomics' Retained Earnings history includes 9 quarters.

  • Across earlier years, Retained Earnings came in at -$700.82 million in FY2024, -$646.97 million in FY2023, -$474.6 million in FY2022 and -$235.44 million in FY2021.
  • Quarterly Retained Earnings has ranged from -$713.4 million in Q2 2025 to -$281,672 in Q2 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 37.97 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 168.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -16.19 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 66.22 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 12.59 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -19.81 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.11 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 115.33 Bn
10 Apollomics 40.08 Mn -1.02 Mn - -711.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -711.80 Mn
Jun 30, 2025 -713.40 Mn
Dec 31, 2024 -700.82 Mn
Jun 30, 2024 -682.17 Mn
Dec 31, 2023 -646.97 Mn
Jun 30, 2023 -625.10 Mn
Dec 31, 2022 -474.60 Mn
Jun 30, 2022 -281,672.00
Dec 31, 2021 -235.44 Mn
API Access

Apollomics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=APLM&period=max&api_key=YOUR_API_KEY